RUVYMRU

Live / Applied — Second extension granted (statement of use) (as of 03 Feb 2026)

What this means for you

Not registered yet, but its 19 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98322374
Mark type
Stylized text
Filed
19 Dec 2023
Published for opposition
17 Dec 2024
Attorney of record
Karen Won

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors

Owner

Prosecution history

  • 04 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Feb 2026 — SOU EXTENSION 2 GRANTED
  • 03 Feb 2026 — SOU EXTENSION 2 FILED
  • 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
  • 15 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 15 Jul 2025 — SOU EXTENSION 1 GRANTED
  • 15 Jul 2025 — SOU EXTENSION 1 FILED
  • 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
  • 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 17 Dec 2024 — PUBLISHED FOR OPPOSITION
  • 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 16 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 16 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 15 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy